Delivery Order SPE2DB20D1109-SPE2DB24FN29K
Award Date
12/20/23
Potential Completion Date
1/12/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of XEOMIN 100 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $3,145.44, has an ultimate completion date of August 13, 2024. As an Indefinite Delivery Contract (IDC) vehicle with a ceiling of up to $999,999,999 through December 2025, this award supports the DLA's efforts to provide a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,106.25 firm fixed-price delivery order is for the supply of XEOMIN 200 unit vials. The contract is not designated with a set-aside and has an ultimate completion date of August 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order worth $4,193.92 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The contract is for the delivery of 4,560,572,353 units of XEOMIN 200 unit vials, a pharmaceutical product, with a period of performance through May 3, 2023. This award is not designated as a set-aside and was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,627.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of January 9, 2025. The contract is not set aside for any specific business designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $4,193.92 for the delivery of 4,561,527,065 units of the drug XEOMIN (200 unit vials) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, with an ultimate completion date of August 7, 2023, was awarded on July 17, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,423.60 firm fixed-price delivery order is for the supply of 4,566,559,466 units of XEOMIN 100 unit vials, with a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,352.44 firm fixed-price delivery order is for the supply of 4,567,425,991 units of the drug XEOMIN, a medication used for various medical conditions. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award, with a ceiling value of $1,396.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, provides for the procurement of XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of February 6, 2025 and uses a firm-fixed-price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.40, is for the delivery of 4,566 units of XEOMIN 100 unit vials. This is a firm fixed-price delivery order contract with a completion date of November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,067.70 firm fixed-price delivery order is for the supply of XEOMIN 100 unit vials, with a completion date of December 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...